168 related articles for article (PubMed ID: 34408224)
1. Inverse association between use of broad spectrum penicllin with beta-lactamase inhibitors and prevalence of type 1 diabetes mellitus in Europe.
Ternák G; Berényi K; Kun S; Szigeti N; Decsi T; Sütő G; Wittmann I
Sci Rep; 2021 Aug; 11(1):16768. PubMed ID: 34408224
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Consumption Patterns in European Countries Might Be Associated with the Prevalence of Type 1 and 2 Diabetes.
Ternák G; Németh M; Rozanovic M; Bogár L
Front Endocrinol (Lausanne); 2022; 13():870465. PubMed ID: 35600582
[TBL] [Abstract][Full Text] [Related]
3. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe.
Ferech M; Coenen S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):408-12. PubMed ID: 16735415
[TBL] [Abstract][Full Text] [Related]
4. Association of antibiotic-consumption patterns with the prevalence of hematological malignancies in European countries.
Ternák G; Berényi K; Németh B; Szenczi Á; Márovics G; Kiss I
Sci Rep; 2022 May; 12(1):7821. PubMed ID: 35550556
[TBL] [Abstract][Full Text] [Related]
5. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009).
Versporten A; Coenen S; Adriaenssens N; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi13-23. PubMed ID: 22096062
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase inhibitors: the story so far.
Pérez-Llarena FJ; Bou G
Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
[TBL] [Abstract][Full Text] [Related]
7. Human metallo-β-lactamase enzymes degrade penicillin.
Diene SM; Pinault L; Keshri V; Armstrong N; Khelaifia S; Chabrière E; Caetano-Anolles G; Colson P; La Scola B; Rolain JM; Pontarotti P; Raoult D
Sci Rep; 2019 Aug; 9(1):12173. PubMed ID: 31434986
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
Sfeir MM; Askin G; Christos P
Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
[TBL] [Abstract][Full Text] [Related]
9. Broad Spectrum β-Lactamase Inhibition by a Thioether Substituted Bicyclic Boronate.
Parkova A; Lucic A; Krajnc A; Brem J; Calvopiña K; Langley GW; McDonough MA; Trapencieris P; Schofield CJ
ACS Infect Dis; 2020 Jun; 6(6):1398-1404. PubMed ID: 31841636
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study.
De Angelis G; Restuccia G; Venturiello S; Cauda R; Malhotra-Kumar S; Goossens H; Schrenzel J; Tacconelli E
BMC Infect Dis; 2012 Mar; 12():74. PubMed ID: 22458427
[TBL] [Abstract][Full Text] [Related]
11. Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx.
Reed BD; Huck W; Zazove P
J Fam Pract; 1991 Feb; 32(2):138-44. PubMed ID: 1990041
[TBL] [Abstract][Full Text] [Related]
12. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
Buynak JD
Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
[TBL] [Abstract][Full Text] [Related]
13. Dominant Antibiotic Consumption Patterns Might Be Associated With the Prevalence of Multiple Sclerosis in European Countries.
TernÁk G; BerÉnyi K; MÁrovics G; SÜmegi A; Fodor B; NÉmeth B; Kiss I
In Vivo; 2020; 34(6):3467-3472. PubMed ID: 33144455
[TBL] [Abstract][Full Text] [Related]
14. Beta-lactamase-mediated resistance and opportunities for its control.
Livermore DM
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():25-41. PubMed ID: 9688449
[TBL] [Abstract][Full Text] [Related]
15. Penicillin sulfone inhibitors of class D beta-lactamases.
Drawz SM; Bethel CR; Doppalapudi VR; Sheri A; Pagadala SR; Hujer AM; Skalweit MJ; Anderson VE; Chen SG; Buynak JD; Bonomo RA
Antimicrob Agents Chemother; 2010 Apr; 54(4):1414-24. PubMed ID: 20086146
[TBL] [Abstract][Full Text] [Related]
16. Beta-lactamase inhibitors from laboratory to clinic.
Bush K
Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
[TBL] [Abstract][Full Text] [Related]
17. "Growth-Promoting Effect" of Antibiotic Use Could Explain the Global Obesity Pandemic: A European Survey.
Ternák G; Németh M; Rozanovic M; Márovics G; Bogár L
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289981
[TBL] [Abstract][Full Text] [Related]
18. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
[TBL] [Abstract][Full Text] [Related]
19. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
20. Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations.
Bush LM; Johnson CC
Infect Dis Clin North Am; 2000 Jun; 14(2):409-33, ix. PubMed ID: 10829263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
